ENTPD1 and B-cell chronic lymphocytic leukemia: Specifically, the proliferating Ki-67+ CLL fraction expresses CD39 at higher levels compared to the resting population that showed consistently weaker expression, suggesting a role in disease aggressiveness (153, 154).